Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL125978 | 0.98 | KDM4E (0.31) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL31386632 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| Rubidium SCHEMBL31257199 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| Magnesium SCHEMBL31257200 | 0.95 | KDM4E (0.34) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL18956275 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL31523974 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL15018678 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| Hydrochloric Acid SCHEMBL5318480 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| SCHEMBL11741955 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 | |
| Calcium SCHEMBL31257197 | 0.95 | KDM4E (0.30) | KDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813670-B | Large-steric-hindrance C-C coupled palladium ligand and synthesis method thereof | 西安欧得光电材料有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122010807-A | Preparation method of negative charge highly delocalized sulfimide alkali metal salt | 华中科技大学 | 2026-05-12 | — | — | CN | claimed |
| US-20250214938-A1 | PROCESS FOR PREPARING ((1S,2S)-2-(5-METHYLPYRIDIN-2-YL)CYCLOPROPYL)-METHANOL | MERCK SHARP & DOHME LLC (US) | 2025-07-03 | — | — | US | claimed |
| CN-117399070-B | Chiral metal synergistic catalytic system containing chelating ligand and application of chiral metal synergistic catalytic system in asymmetric synthesis of bedaquiline | 上海交通大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119954609-A | 2-Iodo-3, 4,5,6-d4Process for the preparation of phenol | 广州瑞安博医药科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| WO-2025097020-A1 | PROCESS FOR POLYETHYLENE GLYCOL SYNTHESIS | Design Therapeutics, Inc. (US) | 2025-05-08 | — | — | WO | claimed |
| EP-4543430-A1 | SYNTHESIS OF TETRAHYDRONAPHTHALENOLS AND USES THEREOF | IO Therapeutics, Inc. (US) | 2025-04-30 | — | — | EP | claimed |
| CN-119894883-A | Methods and processes for preparing MCT4 inhibitors | 维托尔股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119735606-A | Preparation method of gem-bis (boron group) -containing cyclopropane compound | 南京工业大学 | 2025-04-01 | — | — | CN | claimed |
| CN-119731161-A | Lysergic acid derivatives and methods | 佛罗里达州立大学研究基金会有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-1370171-A | Process for preparing nucleoside metabolism inhibitors | IND RES LTD (NZ) | 2002-09-18 | — | — | CN | claimed |
| CN-1353684-A | Ether compounds, compositions and uses thereof | ESPERION THERAPEUTICS INC (US) | 2002-06-12 | — | — | CN | claimed |
| CN-1066723-C | Intermediates for HIV protease inhibitors and process for preparing the same | MERCK & CO INC (US) | 2001-06-06 | — | — | CN | claimed |
| US-6207846-B1 | REACTING 3-ARYL-1,1,2-TRIFLUORO-1-PROPENE WITH A REDUCING AGENT; THEN A LITHIUM BASE; THEN ARYLCHLOROSILANE COMPOUND | AMERICAN CYANAMID CO. | 2001-03-27 | — | — | US | claimed |
| US-6159956-A | Process and intermediate compounds for the preparation of difluorovinylsilane insecticidal and acaricidal agents | AMERICAN CYANAMID CO. (US) | 2000-12-12 | — | — | US | claimed |
| CN-1046715-C | Process for preparing HIV protease inhibitors | MERCK & CO INC (US) | 1999-11-24 | — | — | CN | claimed |
| CN-1046261-C | Synthesis of taxol and its derivatives | UNIV FLORIDA STATE (US) | 1999-11-10 | — | — | CN | claimed |
| CN-1137789-A | Synthesis of taxol and its derivatives | UNIV FLORIDA STATE (US) | 1996-12-11 | — | — | CN | claimed |
| CN-1130905-A | Process for preparing HIV protease inhibitors | MERCK & CO INC (US) | 1996-09-11 | — | — | CN | claimed |
| CN-1130380-A | Process for preparing HIV protease inhibitors | MERCK & CO INC (US) | 1996-09-04 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214938-A1 | PROCESS FOR PREPARING ((1S,2S)-2-(5-METHYLPYRIDIN-2-YL)CYCLOPROPYL)-METHANOL | DHPS, CYP2S1, CYP51A1 | KDM4E 527/4885ALDH1A1 1671/4885HSD17B10 1679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.